引用次数
引用: 6,077
H-指数: 25
I10-指数 : 35
出版物: 122
Screening of Y chromosome microdeletion which contains AZF regions in 71 Turkish azoospermic men.
E Tavmergen , F Ozkinay , S Pehlivan , E N Tavmergen-Goker
Genetic Counseling 15 ( 2) 199 -205
9
2004
Enzymes of the thymidylate cycle as targets for chemotherapeutic agents: mechanisms of resistance.
T. Trippett , J. Lin , Debabrata Bajerjee , J. R. Bertino
Mount Sinai Journal of Medicine 59 ( 5) 391 -395
6
1992
446PD Second-line afatinib vs erlotinib for patients with squamous cell carcinoma of the lung in LUX-Lung 8: analysis of tumor and serum biomarkers
E. Ehrnrooth , N. Krämer , S.M. Gadgeel , G. Goss
Annals of Oncology 27
2016
OP047 EPA ENRICHED NUTRITIONAL SUPPORT AND FAST TRACK SURGERY FOR ELECTIVE PERIAMPULLARY CARCINOMA
A. Coker , B. Gurcu , A. Uguz , D. Hopanci Bicakli
Clinical Nutrition Supplements 5 ( 2) 20
2010
Potential predictive factors for response to weekly paclitaxel treatment in patients with metastatic breast cancer.
C. Sezgin , B. Karabulut , R. Uslu , U.A. Sanli
Journal of Chemotherapy 17 ( 1) 96 -103
17
2005
Effects of oral nutrition support on quality of life in cachectic pancreatic cancer patients
A. Coker , D.B. Hopanci , A. Uguz , O.V. Unalp
Hpb 20
2018
SUN-P076: Effects of Oral Nutrition Support on Quality of Life in Cachectic Pancreatic Cancer Patients
A. Coker , D.B. Hopanci , N. Oruc , A. Aydin
Clinical Nutrition 36
2017
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study.
B. Schultheis , D. Reuter , M.P. Ebert , J. Siveke
Annals of Oncology 28 ( 10) 2429 -2435
46
2017
Randomized phase 3 trial of irinotecan (CPT-11) + 5FU/folinic acid (FA) vs CDDP + 5FU in 1st-line advanced gastric cancer patients
M. Dank , J. Zaluski , C. Barone , V. Valvere
Journal of Clinical Oncology 23 ( 16_suppl) 4003 -4003
83
2005
Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens.
R. Uslu , U.A. Sanli , Y. Dikmen , B. Karabulut
International Journal of Gynecological Cancer 15 ( 2) 240 -245
29
2005
Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma
E. Kurt , C. Sezgin , T. Evrensel , U. Yalcinkaya
International Journal of Clinical Practice 59 ( 5) 537 -543
7
2005
Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction
M. Dank , J. Zaluski , C. Barone , V. Valvere
Annals of Oncology 19 ( 8) 1450 -1457
270
2008
Oral uracil/tegafur (UFT) plus leucovorin (LV) in patients with metastatic colorectal cancer (CRC)
E. Goker , N.F. Aykan , S. Serdengecti , N. Gunel
European Journal of Cancer 35
1
1999
Pancreatic resections for advanced M1-pancreatic carcinoma
A. Uguz , O. Unalp , R. Ortac , G. Akpinar
Hpb 21
2019
Evaluation of VeriStrat, a serum proteomic test, in the randomized, open-label, Phase 3 LUX-Lung 8 trial of afatinib versus erlotinib for the second-line treatment of advanced squamous cell carcinoma of the lung
G. Goss , K.H. Lee , E. Felip , M. Cobo
Annals of Oncology 27
2
2016
215 A randomized, multinational phase III study in first line metastatic and locally recurrent gastric cancer (MGC): CPT-11 plus 5-fluorouracil (5-FU)/leucovorin (LV) versus cisplatinum (CDDP) plus 5-FU
M. Dank , J. Zaluski , C. Barone , V. Valvere
Ejc Supplements 1 ( 5)
5
2003
Capecitabine (X) monotherapy in patients (pts) with pretreated metastatic breast cancer (MBC): Is response correlated to cerbB-2 expression?
V. C. Sezgin , U. A. Sanli , B. Karabulut , R. Uslu
Journal of Clinical Oncology 22 760 -760
2
2004
The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients
G. Basaran , S. Saglam , S. Tansan , M. Demirel
Journal of Clinical Oncology 29
2011
Postoperative gemcitabine alone and concurrent with radiation therapy in locally advanced pancreatic carcinoma.
S. Demirci , S. Ozkok , D. Yalman , M. Zeytunlu
Journal of Clinical Oncology 28
2010
340 Detection of IL-1 ß, IL-5 and TNF-a in Cultures of Primary Gastrointestinal or Breast Cancer Cells After Treatment
H.S. Vatansever , K. Ozbilgin , H. Aydede , E. Goker
European Journal of Cancer 48
2012